SCHEMBL21990184

SCHEMBL21990184

Cc1ccc(CNC(=O)c2ccc3c(c2)N(CCc2ccccc2)C(=O)C3(C)C)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.51
ALDH1A1 P00352 3/20 0.45
USP2 O75604 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
STING1 Q86WV6 1/20 0.43
PPARG P37231 1/20 0.42
PKM P14618 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
DRD2 P14416 1/20 0.41
MAPT P10636 2/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.39
SPR P35270 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21990083 0.86 TP53 (0.47) TP53ALDH1A1TSHRSTING1PPARG
SCHEMBL21990020 0.82 STING1 (0.54) TP53ALDH1A1ALOX15TSHRSTING1
SCHEMBL21990157 0.81 STING1 (0.54) TP53ALDH1A1TSHRSTING1PPARG
SCHEMBL21990102 0.81 STING1 (0.56) TP53ALDH1A1STING1PPARGPKM
SCHEMBL20594670 0.81 TP53 (0.49) TP53ALDH1A1TSHRSTING1PPARG
SCHEMBL21990122 0.81 STING1 (0.64) TP53ALDH1A1STING1PPARGPKM
SCHEMBL21990149 0.80 STING1 (0.50) TP53STING1PPARGMAPT
SCHEMBL31411563 0.80 PARK7 (0.54) TP53ALDH1A1USP2ALOX15HSD17B10
SCHEMBL21989990 0.79 STING1 (0.44) TP53ALDH1A1STING1PPARGMAPT
SCHEMBL21990173 0.79 STING1 (0.55) TP53STING1PPARGGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LIMITED (GB) 2020-06-04 US claimed
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LIMITED (GB) 2020-06-04 US disclosed
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LIMITED (GB) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172483-A1 HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING STING1, IRF3, CGAS TP53 131/4885ALDH1A1 4642/4885USP2 3368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.